Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:02 AM
Ignite Modification Date:
2025-12-25 @ 2:02 AM
NCT ID:
NCT00791960
Eligibility Criteria:
Inclusion Criteria:
* All patients undergoing elective Cesarean deliveries under spinal anesthesia.
* All patients who gave written informed consent to participate in this study.
* ASA I and II patients.
* Full term normal pregnancy.
Exclusion Criteria:
* All patients who refuse to give written informed consent.
* All patients who claim allergy or hypersensitivity to dimenhydrinate.
* Patients with history of vomiting within 24 hours prior to Cesarean delivery.
* Patients with history of gastrointestinal or psychiatric diseases and morbid obesity
* Patients receiving any of the following drugs within 24 hours before the study: opioids, antiemetics, H2 antagonists, phenothiazine and corticosteroids.
* Patients with severe pregnancy induced hypertension
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
50 Years
Study:
NCT00791960
Study Brief:
Protocol Section:
NCT00791960